By Howard Wolinsky The uptake of prostate cancer screening might be expected to tail off in men 70 to 85 based on U.S. Preventative Services Task Force recommendations against routune screening going back nearly 20 years ago. Instead, new studies show that the screening rates in these men remain about the same or are even higher than those found in younger men who